| Literature DB >> 34373458 |
Anthony P West1, Joel O Wertheim2, Jade C Wang3, Tetyana I Vasylyeva2, Jennifer L Havens4, Moinuddin A Chowdhury3, Edimarlyn Gonzalez3, Courtney E Fang3, Steve S Di Lonardo3, Scott Hughes3, Jennifer L Rakeman3, Henry H Lee5,6, Christopher O Barnes7, Priyanthi N P Gnanapragasam7, Zhi Yang7, Christian Gaebler8, Marina Caskey8, Michel C Nussenzweig8,9, Jennifer R Keeffe7, Pamela J Bjorkman7.
Abstract
Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detect an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V. This lineage was first sequenced in late November 2020. Phylodynamic inference confirmed the rapid growth of the B.1.526 lineage. In concert with other variants, like B.1.1.7, the rise of B.1.526 appears to have extended the duration of the second wave of COVID-19 cases in NYC in early 2021. Pseudovirus neutralization experiments demonstrated that B.1.526 spike mutations adversely affect the neutralization titer of convalescent and vaccinee plasma, supporting the public health relevance of this lineage.Entities:
Year: 2021 PMID： 34373458 DOI： 10.1038/s41467-021-25168-4
Source DB: PubMed Journal: Nat Commun ISSN： 2041-1723 Impact factor: 14.919